Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cybrid Technologies Inc. (603212.SS)
Suzhou, CN
Headquartered in Suzhou, China, Cybrid Technologies Inc. was established in 2006 and specializes in the production and distribution of thin-film polymer functional materials across China. The company offers an extensive portfolio of products, including essential components for solar modules such as backsheets and encapsulant films. Their diverse offerings also encompass various specialized adhesive solutions like insulation patches, repairing tapes, positioning tapes, single-sided framing adhesive tapes, and C-type high-temperature products. Additionally, they supply tapes for mobile graphite sheet heat dissipation, black shading PET double-sided applications, speakers, dicing, thin double-sided cotton, insulation, and stiffening, alongside protective films and thermal conductive pads, as well as electronic conductive tapes.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.09% | +6.86% | +17.03% | -3.82% | +23.23% | +5.81% | +52.88% | -26.46% | -33.89% | +0.40% | +0.40% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-12.8% Q1'26: -6.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+6.2% Q1'26: +67.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-3.4% Q1'26: -4.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-9.6% Q1'26: -1.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-8.5% Q1'26: -0.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.2% ★ Q1'26: +5.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-8.14× Q1'26: -41.16× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
2.18B
est: 2.37B (-8.0%)
|
3.02B
est: 3.02B (+0.0%)
|
4.12B
est: 4.44B (-7.3%)
|
4.17B
est: 3.60B (+15.8%)
|
3.00B
est: 3.00B (+0.3%)
|
2.62B
est: 3.16B (-17.1%)
|
3.83B
3.83B – 3.83B
+21.1% YoY
|
4.89B
4.89B – 4.89B
+27.7% YoY
|
| EBITDA |
271.01M
est: 139.92M (+93.7%)
|
277.63M
est: 178.02M (+56.0%)
|
317.41M
est: 262.05M (+21.1%)
|
224.52M
est: 85.79M (+161.7%)
|
-166.07M
est: 71.46M (-332.4%)
|
-127.06M
est: 75.43M (-268.4%)
|
91.36M
91.36M – 91.36M
+21.1% YoY
|
116.62M
116.62M – 116.62M
+27.7% YoY
|
| EBIT |
238.97M
est: 85.09M (+180.8%)
|
224.68M
est: 108.26M (+107.5%)
|
236.34M
est: 159.36M (+48.3%)
|
131.77M
est: -17.19M (+866.4%)
|
-276.00M
est: -14.32M (-1,827.1%)
|
-250.35M
est: -15.12M (-1,556.0%)
|
-18.31M
-18.31M – -18.31M
-21.1% YoY
|
-23.37M
-23.37M – -23.37M
-27.7% YoY
|
| Net Income |
194.09M
est: 219.18M (-11.4%)
|
170.09M
est: 184.11M (-7.6%)
|
171.25M
est: 288.44M (-40.6%)
|
103.61M
est: 41.68M (+148.6%)
|
-284.93M
est: -118.12M (-141.2%)
|
-267.94M
est: -32.81M (-716.6%)
|
153.12M
153.12M – 153.12M
+566.7% YoY
|
157.50M
157.50M – 157.50M
+2.9% YoY
|
| SGA |
71.84M
est: 51.40M (+39.8%)
|
106.56M
est: 65.39M (+63.0%)
|
127.82M
est: 96.26M (+32.8%)
|
85.49M
est: 122.15M (-30.0%)
|
102.23M
est: 101.76M (+0.5%)
|
128.09M
est: 107.40M (+19.3%)
|
130.08M
130.08M – 130.08M
+21.1% YoY
|
166.05M
166.05M – 166.05M
+27.7% YoY
|
| EPS |
0.50
est: 0.50 (+0.0%)
|
0.42
est: 0.42 (+0.0%)
|
0.41
est: 0.66 (-37.7%)
|
0.24
est: 0.10 (+151.9%)
|
-0.65
est: -0.27 (-140.7%)
|
-0.61
est: -0.08 (-713.3%)
|
0.35
0.35 – 0.35
+566.7% YoY
|
0.36
0.36 – 0.36
+2.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 304.2K | 0.06% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 64.4K | 0.39% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 52.4K | 0.29% |
| 4 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 7.6K | 0.48% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 17.1K | 0.26% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 64.1K | 0.28% |
| 7 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 841.5K | 0.06% |
| 8 | Vanguard ESG International Stock ETF VSGX | 0.00% | 10.7K | 0.10% |
| 9 | Vanguard Total International Stock ETF VXUS | 0.00% | 883.3K | 0.05% |
| 10 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 1.4K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hongye Chen | Deputy GM & Director | — | male |
| Jian Bo Deng | Chairman of the Supervisory Board, R&D Director and Deputy CTO | — | male |
| Mian Wu | General Manager | — | male |
| Wenqin Yan | Accounting Supervisor, Chief Financial Officer & Director | — | female |
| Xiaoying Chen | Board Secretary | — | female |
| Zaibo Gao | Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603212.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
